Category: Mindray Medical International Ltd.
The U.S. Defense Dept. picks up a 5th option year worth nearly $60 million on its contract with Mindray for patient monitoring equipment.
Ottoman Bay Research analysts claim they've finally found the "smoking gun" that proves their accusations that Mindray Medical isn't what it seems.
MASSDEVICE ON CALL — Analysts at short-seller Ottoman Bay Research, which have long held that Mindray Medical (NYSE:MR) management has misled investors, claim that they've found the so-called "smoking gun" that proves their accusations.
Short-seller Ottoman Bay Research issues another report accusing Mindray Medical's management of misleading investors.
Short-seller Ottoman Bay Research took another shot at Mindray Medical (NYSE:MR) this week, taking issue with the Chinese medical device company's response to Ottoman's initial accusations of fraud and mismanagement.
Shares of Mindray Medical, which lost 11% yesterday after a short seller issued a report alleging fraud, rebounded a bit today after the Chinese medtech company denied the accusations.
Chinese medical device maker Mindray Medical pays $15 million to settle a "commercial dispute" with Beckman Coulter.
China-based Mindray Medical lowered its full-year financial outlook on sluggish hospital purchases at home, even as sales and profits each gain 15% during the company's 3rd quarter.
Medical device companies including Cardinal Health and Mindray Medical are among the firms awarded contracts and extensions worth nearly $196 million by the U.S. Defense Dept.
The U.S. Defense Dept. awarded $195.8 million worth of contracts to 3 medical device firms.